The Presence of EGFR T790M in TKI-Naïve Lung Cancer Samples of Patients Who Developed a T790M-Positive Relapse on First or Second Generation TKI Is Rare
Li, Weiting, Kok, Klaas, Tan, Geok Wee, Meng, Pei, Mastik, Mirjam, Rifaela, Naomi, Scherpen, Frank, Hiltermann, T Jeroen N, Groen, Harry J M, Wekken, Anthonie J van der, van den Berg, Anke
Published in Cancers (19.07.2022)
Published in Cancers (19.07.2022)
Get full text
Journal Article
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
Paik, Paul K, Felip, Enriqueta, Veillon, Remi, Sakai, Hiroshi, Cortot, Alexis B, Garassino, Marina C, Mazieres, Julien, Viteri, Santiago, Senellart, Helene, Van Meerbeeck, Jan, Raskin, Jo, Reinmuth, Niels, Conte, Pierfranco, Kowalski, Dariusz, Cho, Byoung Chul, Patel, Jyoti D, Horn, Leora, Griesinger, Frank, Han, Ji-Youn, Kim, Young-Chul, Chang, Gee-Chen, Tsai, Chen-Liang, Yang, James C.-H, Chen, Yuh-Min, Smit, Egbert F, van der Wekken, Anthonie J, Kato, Terufumi, Juraeva, Dilafruz, Stroh, Christopher, Bruns, Rolf, Straub, Josef, Johne, Andreas, Scheele, Jürgen, Heymach, John V, Le, Xiuning
Published in The New England journal of medicine (03.09.2020)
Published in The New England journal of medicine (03.09.2020)
Get full text
Journal Article
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
Boonstra, Pieter A., Wind, Thijs T., van Kruchten, Michel, Schuuring, Ed, Hospers, Geke A. P., van der Wekken, Anthonie J., de Groot, Derk-Jan, Schröder, Carolien P., Fehrmann, Rudolf S. N., Reyners, Anna K. L.
Published in Cancer and metastasis reviews (01.09.2020)
Published in Cancer and metastasis reviews (01.09.2020)
Get full text
Journal Article
Molecular imaging biomarkers for immune checkpoint inhibitor therapy
van de Donk, Pim P, Kist de Ruijter, Laura, Lub-de Hooge, Marjolijn N, Brouwers, Adrienne H, van der Wekken, Anthonie J, Oosting, Sjoukje F, Fehrmann, Rudolf Sn, de Groot, Derk Jan A, de Vries, Elisabeth Ge
Published in Theranostics (2020)
Published in Theranostics (2020)
Get full text
Journal Article
Book Review
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer
Veggel, Bianca A. M. H., Wekken, Anthonie J., Paats, Marthe S., Hendriks, Lizza E. L., Hashemi, Sayed M. S., Daletzakis, Antonios, Broek, Daan, Bosch, Linda J. W., Monkhorst, Kim, Smit, Egbert F., Langen, Adrianus J.
Published in Cancer (01.03.2024)
Published in Cancer (01.03.2024)
Get full text
Journal Article
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations
Drilon, Alexander, Horan, Joshua C, Tangpeerachaikul, Anupong, Besse, Benjamin, Ou, Sai-Hong Ignatius, Gadgeel, Shirish M, Camidge, D Ross, van der Wekken, Anthonie J, Nguyen-Phuong, Linh, Acker, Adam, Keddy, Clare, Nicholson, Katelyn S, Yoda, Satoshi, Mente, Scot, Sun, Yuting, Soglia, John R, Kohl, Nancy E, Porter, James R, Shair, Matthew D, Zhu, Viola, Davare, Monika A, Hata, Aaron N, Pelish, Henry E, Lin, Jessica J
Published in Cancer discovery (01.03.2023)
Published in Cancer discovery (01.03.2023)
Get full text
Journal Article
CT‐guided percutaneous hookwire localization increases the efficacy and safety of VATS for pulmonary nodules
Klinkenberg, Theo J., Dinjens, Lars, Wolf, Rienhart F. E., van der Wekken, Anthonie J., van de Wauwer, Caroline, de Bock, Geertruida H., Timens, Wim, Mariani, Massimo A., Groen, Harry J. M.
Published in Journal of surgical oncology (01.06.2017)
Published in Journal of surgical oncology (01.06.2017)
Get full text
Journal Article
Amivantamab Compared with Real-World Physician’s Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations
Christopoulos, Petros, Girard, Nicolas, Proto, Claudia, Soares, Marta, Lopez, Pilar Garrido, van der Wekken, Anthonie J., Popat, Sanjay, Diels, Joris, Schioppa, Claudio A., Sermon, Jan, Rahhali, Nora, Pick-Lauer, Corinna, Adamczyk, Agnieszka, Penton, James, Wislez, Marie
Published in Cancers (08.11.2023)
Published in Cancers (08.11.2023)
Get full text
Journal Article
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study
Gijtenbeek, Rolof G.P., Damhuis, Ronald A.M., van der Wekken, Anthonie J., Hendriks, Lizza E.L., Groen, Harry J.M., van Geffen, Wouter H.
Published in The Lancet regional health. Europe (01.04.2023)
Published in The Lancet regional health. Europe (01.04.2023)
Get full text
Journal Article
Molecular imaging to support cancer immunotherapy
van de Donk, Pim P, Oosting, Sjoukje F, Knapen, Daan G, van der Wekken, Anthonie J, Brouwers, Adrienne H, Lub-de Hooge, Marjolijn N, de Groot, Derk-Jan A, de Vries, Elisabeth GE
Published in Journal for immunotherapy of cancer (01.08.2022)
Published in Journal for immunotherapy of cancer (01.08.2022)
Get full text
Journal Article
Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib
de Jager, Vincent D., Stigt, Jos A., Niemantsverdriet, Maarten, ter Elst, Arja, van der Wekken, Anthonie J.
Published in NPJ precision oncology (22.05.2024)
Published in NPJ precision oncology (22.05.2024)
Get full text
Journal Article
A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses
Koopman, Bart, Cajiao Garcia, Betzabel N, Kuijpers, Chantal C H J, Damhuis, Ronald A M, van der Wekken, Anthonie J, Groen, Harry J M, Schuuring, Ed, Willems, Stefan M, van Kempen, Léon C
Published in Cancers (20.07.2021)
Published in Cancers (20.07.2021)
Get full text
Journal Article
Baseline Blood CD8 + T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer
Kievit, Hanneke, Muntinghe-Wagenaar, M Benthe, Abdulahad, Wayel H, Rutgers, Abraham, Hijmering-Kappelle, Lucie B M, Hiddinga, Birgitta I, Ubbels, J Fred, Wijsman, Robin, van der Leij, Marcel J, Bijzet, Johan, Groen, Harry J M, Kerstjens, Huib A M, van der Wekken, Anthonie J, Kroesen, Bart-Jan, Hiltermann, T Jeroen N
Published in Cancers (19.07.2024)
Published in Cancers (19.07.2024)
Get full text
Journal Article
Concomitant mutation status of ALK -rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib
Li, Jingjing, Zhang, Bin, Zhang, Yu, Xu, Feng, Zhang, Zhenfa, Shao, Lin, Yan, Chunhe, Ulivi, Paola, Denis, Marc G, Christopoulos, Petros, Thomas de Montpréville, Vincent, Bernicker, Eric H, van der Wekken, Anthonie J, Wang, Changli, Yue, Dongsheng
Published in Translational lung cancer research (01.03.2021)
Published in Translational lung cancer research (01.03.2021)
Get full text
Journal Article
CX Chemokine Receptor 7 Contributes to Survival of KRAS -Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor
Liu, Bin, Song, Shanshan, Setroikromo, Rita, Chen, Siwei, Hu, Wenteng, Chen, Deng, van der Wekken, Anthonie J, Melgert, Barbro N, Timens, Wim, van den Berg, Anke, Saber, Ali, Haisma, Hidde J
Published in Cancers (30.03.2019)
Published in Cancers (30.03.2019)
Get full text
Journal Article
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)
Meertens, Marinda, Muntinghe-Wagenaar, M Benthe, Sikkema, Barend J, Lopez-Yurda, Marta, Retèl, Valesca P, Paats, Marthe S, Ter Heine, Rob, Schuuring, Ed, Timens, Wim, Touw, Daan J, van Boven, Job F M, de Langen, Adrianus J, Hashemi, Sayed M S, Hendriks, Lizza E L, Croes, Sander, van den Heuvel, Michel M, Dingemans, Anne-Marie C, Mathijssen, Ron H J, Smit, Egbert F, Huitema, Alwin D R, Steeghs, Neeltje, van der Wekken, Anthonie J
Published in Frontiers in oncology (09.03.2023)
Published in Frontiers in oncology (09.03.2023)
Get full text
Journal Article
89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
Bensch, Frederike, van der Veen, Elly L., Lub-de Hooge, Marjolijn N., Jorritsma-Smit, Annelies, Boellaard, Ronald, Kok, Iris C., Oosting, Sjoukje F., Schröder, Carolina P., Hiltermann, T. Jeroen N., van der Wekken, Anthonie J., Groen, Harry J. M., Kwee, Thomas C., Elias, Sjoerd G., Gietema, Jourik A., Bohorquez, Sandra Sanabria, de Crespigny, Alex, Williams, Simon-Peter, Mancao, Christoph, Brouwers, Adrienne H., Fine, Bernard M., de Vries, Elisabeth G. E.
Published in Nature medicine (01.12.2018)
Published in Nature medicine (01.12.2018)
Get full text
Journal Article
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC
Wei, Jiacong, Meng, Pei, Terpstra, Miente Martijn, van Rijk, Anke, Tamminga, Menno, Scherpen, Frank, ter Elst, Arja, Alimohamed, Mohamed Z., Johansson, Lennart F., Stigt, Jos, Gijtenbeek, Rolof P. G., van Putten, John, Hiltermann, T. Jeroen N., Groen, Harry J. M., Kok, Klaas, van der Wekken, Anthonie J., van den Berg, Anke
Published in Targeted oncology (01.03.2021)
Published in Targeted oncology (01.03.2021)
Get full text
Journal Article
An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients
Wei, Jiacong, Rybczynska, Anna A., Meng, Pei, Terpstra, Martijn, Saber, Ali, Sietzema, Jantine, Timens, Wim, Schuuring, Ed, Hiltermann, T. Jeroen N., Groen, Harry. J.M., van der Wekken, Anthonie, van den Berg, Anke, Kok, Klaas
Published in Cancers (01.10.2020)
Published in Cancers (01.10.2020)
Get full text
Journal Article
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort
Zou, Zihua, Gu, Yangchun, Liang, Li, Hao, Xuezhi, Fan, Chengjuan, Xin, Tao, Zhao, Songchen, Liu, Ziling, Guo, Ye, Ma, Kewei, Li, Haojing, Zhang, Cuiying, Shan, Li, Zhang, Yan, Dong, Guilan, Peng, Yumei, Shen, Fangfang, Song, Xia, Christopoulos, Petros, van der Wekken, Anthonie J, Okuda, Katsuhiro, Ekman, Simon, Xing, Puyuan, Li, Junling
Published in Translational lung cancer research (01.12.2022)
Published in Translational lung cancer research (01.12.2022)
Get full text
Journal Article